Molecular mechanisms of insulin resistance and associated diseases

被引:188
作者
Mlinar, Barbara
Marc, Janja
Janez, Andrej
Pfeifer, Marija
机构
[1] Univ Ljubljana, Dept Clin Biochem, Fac Pharm, SI-1000 Ljubljana, Slovenia
[2] Univ Ljubljana, Ctr Med, Dept Endocrinol & Metab Dis, Ljubljana, Slovenia
关键词
diabetes mellitus type 2; insulin resistance; lipodystrophy; metabolic syndrome; obesity; polycystic ovary syndrome;
D O I
10.1016/j.cca.2006.07.005
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
insulin resistance is a state in which higher than normal concentrations of insulin are required for normal response. The most common underlying cause is central obesity, although primary insulin resistance in normal-weight individuals is also possible. Excess abdominal adipose tissue has been shown to release increased amounts of free fatty acids which directly affect insulin signalling, diminish glucose uptake in muscle, drive exaggerated triglyceride synthesis and induce gluconeogenesis in the liver. Other factors presumed to play the role in insulin resistance are tumour necrosis factor alpha, adiponectin, leptin, IL-6 and some other adipokines. Hyperinsulinaemia which accompanies insulin resistance may be implicated in the development of many pathological states, such as hypertension and hyperandrogenaemia. Insulin resistance underlies metabolic syndrome and is farther associated with polycystic ovary syndrome and lipodystrophies. When IS-cells fail to secrete the excess insulin needed, diabetes mellitus type 2 emerges, which is, besides coronary heart disease, the main complication of insulin resistance and associated diseases. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:20 / 35
页数:16
相关论文
共 141 条
[1]   Endothelial dysfunction in endocrine disease [J].
Abdu, TAM ;
Elhadd, T ;
Pfeifer, M ;
Clayton, RN .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2001, 12 (06) :257-265
[2]   Adipokines, inflammation, and the endothelium in diabetes [J].
Waleed Aldhahi ;
Osama Hamdy .
Current Diabetes Reports, 2003, 3 (4) :293-298
[3]   The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes [J].
Altshuler, D ;
Hirschhorn, JN ;
Klannemark, M ;
Lindgren, CM ;
Vohl, MC ;
Nemesh, J ;
Lane, CR ;
Schaffner, SF ;
Bolk, S ;
Brewer, C ;
Tuomi, T ;
Gaudet, D ;
Hudson, TJ ;
Daly, M ;
Groop, L ;
Lander, ES .
NATURE GENETICS, 2000, 26 (01) :76-80
[4]  
AMER P, 1995, ANN MED, V27, P435
[5]   HYPERINSULINEMIA PRODUCES BOTH SYMPATHETIC NEURAL ACTIVATION AND VASODILATION IN NORMAL HUMANS [J].
ANDERSON, EA ;
HOFFMAN, RP ;
BALON, TW ;
SINKEY, CA ;
MARK, AL .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (06) :2246-2252
[6]  
Andrews RC, 1999, CLIN SCI, V96, P513, DOI 10.1042/cs0960513
[7]   Resistin: yet another adipokine tells us that men are not mice [J].
Arner, P .
DIABETOLOGIA, 2005, 48 (11) :2203-2205
[8]   Weak and non-independent association between plasma TAFI antigen levels and the insulin resistance syndrome [J].
Aubert, H ;
Frère, C ;
Aillaud, MF ;
Morange, PE ;
Juhan-Vague, I ;
Alessi, MC .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2003, 1 (04) :791-797
[9]   Resistin: molecular history and prognosis [J].
Banerjee, RR ;
Lazar, MA .
JOURNAL OF MOLECULAR MEDICINE-JMM, 2003, 81 (04) :218-226
[10]   Dominant negative mutations in human PPARγ associated with severe insulin resistance, diabetes mellitus and hypertension [J].
Barroso, I ;
Gurnell, M ;
Crowley, VEF ;
Agostini, M ;
Schwabe, JW ;
Soos, MA ;
Maslen, GL ;
Williams, TDM ;
Lewis, H ;
Schafer, AJ ;
Chatterjee, VKK ;
O'Rahilly, S .
NATURE, 1999, 402 (6764) :880-883